#Myopia Control Lens Market

[lasik-eye-surgery-in-delhi]

Best LASIK Eye Surgery in Delhi - Dr. Rajiv Bajaj for Clear Vision

INTRODUCTION

Get clear vision with LASIK eye surgery in Delhi. Expert care by Dr. Rajiv Bajaj. Safe, effective, and virtually painless. Book your consultation today!

Q. What is LASIK?

A.LASIK, the short form of laser in-situ keratomileusis, is a surgical procedure done to correct the vision. The correction of eyesight is done in patients suffering from myopia, hyperopia, and astigmatism. It is one of the most performed surgery all-overs the world with a high success rate. This procedure provides prolonged freedom from glasses and contact lens to the patient. This surgery comes under the refractive correction procedure as it helps in correcting the refractive errors in vision. The person may experience immediate enhancement in the vision. Barring few complications which can be minimized through proper preoperative evaluation and appropriate surgical technique and expertise the surgery is considered as one of the safest.

Q. How is LASIK surgery performed?

A.LASIK is laser vision correction procedure utilizing a laser called EXCIMER laser. These are high energy beam which transfers the energy to corneal tissues. The surgery is done through computer-controlled laser for high accuracy and precision and the energy so transferred to the corneal tissue causes corneal reshaping by vaporizing a small quantity of tissues.The surgery takes place in two steps. In the FIRST step, a very thin and hinged corneal flap is formed with the help of a laser ( femtolasik or blade free lasik ) or automated microkeratome ( blade lasik ). In the SECOND step, the flap is pulled to expose the underlying corneal tissue and the excimer laser is used to reshape the cornea by removing a small amount of corneal tissue. After reshaping the cornea, the flap is then repositioned on the cornea.

Q. What are the expected results from LASIK surgery?

A.LASIK surgery is performed to avoid the dependency on glasses and contact lenses. Allmost all patients are happy with the outcome. However, the results vary from individual to individual, Various factors affect the quality of results obtained through LASIK surgery. Important are surgeons expertise, the technology used and appropriate patient and technique selection. Preoperative evaluation plays a pivotal role in determing the satisfactory and successful visual outcome. To achieve the best results, a thorough ophthalmological examination is a prerequisite to establishing candidature to undergo LASIK surgery. The experience of the surgeon and the technology used to perform LASIK surgery are other important factors that may make a difference on LASIK outcome.

Q. What are the benefits of LASIK Surgery?

A.The laser is a highly effective and safe surgery for correcting refractive errors. LASER surgery is commonly used to correct myopia, hyperopia, and astigmatism because of various advantages it offers to the patients.Various advantages offered by LASIK surgery include:Outcome: LASIK surgery meets the expectation of almost 96% of the patient in one go and the number further increases through revision surgery. It was introduced in the market almost 25 years ago and is still the mainstay for correcting refractive errors.Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia.Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia.Immediate result: Most patients experienced enhanced vision immediately after surgery while others have improved vision within 24 hours.No stitches: The surgery does not involve any stitches or bandages.

Q. What are the risks with LASIK surgery?

A.LASIK surgery involves certain risk but these can be minimized by the implementation of high-technology instruments, undergoing surgery from an experienced surgeon and adequate post-operative care. Following are some of the complications associated with LASIK surgery:Risk of infection: Antibiotics are prescribed before and after the surgery to minimize or avoid the infection. If the patient fails to adhere to the prescription, the infection may develop in the treated eye.Glare or halos: Glare and halos, especially in the people with large pupil, may also occur after LASIK surgery. It is minimized using an aspheric wavefront optimized profile on the advanced MEL 80 excimer laser systems from CARL ZEISS (GERMANY)Dry Eyes: Dryness may be induced after LASIK surgery through the period differs from patient to patient. Lubricating eye drops are prescribed post-surgery.Fluctuation in the vision: may happen in initial postoperative period but settles within a weeks time.Other rare complications: Other rare but serious complications include scarring, the problem in equipment during surgery, and flap-related complications.

Q. Am I the right candidate for LASIK surgery?

A.For determining the eligibility of the candidate for LASIK surgery, a comprehensive evaluation of the eye is required. Following are the right candidates for LASIK surgery:

Should be over 18 years of age

Should be in a healthy state to bear the stress of surgery.

Should not suffer from any underlying unmanaged medical condition such as unmanaged hypertension or uncontrolled diabetes.

Should not be pregnant or breastfeeding.

Q. How should I choose the best surgeon for LASIK surgery?

A.Choosing the best ophthalmological surgeon for LASIK surgery requires a lot of research and gathering information about various surgeons. Following elements help you in deciding the best surgeon for LASIK surgery:

Experience: The experience of the surgeon is one of the important considerations for safe surgery. Risks of complications increase manifold when an inexperienced surgeon does the surgery. You should always check the experience of the surgeon and the number of LASIK surgeries he had done.

At BAJAJ EYE CARE CENTRE we have experienced surgeons who have done thousands of successful procedures.

Infrastructure: Clinics or hospitals which invest much in infrastructure are believed to have the high-end and latest technology.

Gather information about the technology used during the surgery. BAJAJ EYE CARE CENTRE uses the most advanced technology from the world leaders in laser vision correction procedures – CARL ZEISS VISUMAX FEMTOSECOND LASER machine for blade free lasik and the MEL 80 EXCIMER LASER machine for bladefree and blade lasik. BAJAJ EYE CARE CENTRE is also the first centre to install ZEISS VISUMAX – SMILE machine for flapless and totally blade free lasik in whole of NORTH DELHI.

Success rate: High success rate indicates the expertise of the surgeon in performing LASIK surgery.

Q. Is it safe to undergo LASIK surgery simultaneously on both the eyes?

A.YES. Most of the laser vision correction procedures are done simultaneously on both the eyes. it saves time and restricts the number of visits to the eye centre.

Q. Do I feel pain during LASIK surgery?

A.As the surgery is performed under the effect of anesthesia, the patient does not feel any pain during the surgery. However, after the effect of anesthesia gets reduced, some patients may feel mild discomfort and irritation. However, the discomfort subsides within hours after the procedure.

Q. Will reading glasses be required after LASIK surgery?

A.The need for reading glasses after LASIK surgery depends on your age. No reading glasses are required in less than 40 years of age group.

CONCLUSION

Choosing LASIK eye surgery in Delhi with Dr. Rajiv Bajaj ensures you receive top-tier care and the latest technology for exceptional results. With a high success rate, minimal discomfort, and rapid recovery, LASIK offers an effective solution for those looking to achieve clear, glasses-free vision. Trust in Dr. Bajaj's expertise and advanced technology to transform your vision and improve your quality of life. Book your consultation today and take the first step towards a clearer tomorrow.

[globalgrowthinsights]

Blockchain Technology in Healthcare Market: Dissecting the Factors Steering Growth and Potential Risks

Blockchain Technology in Healthcare Market provides in-depth analysis of the market state of Blockchain Technology in Healthcare manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Blockchain Technology in Healthcare in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Blockchain Technology in Healthcare Market Report:

The report offers a comprehensive and broad perspective on the global Blockchain Technology in Healthcare Market.

The market statistics represented in different Blockchain Technology in Healthcare segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Blockchain Technology in Healthcare are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Blockchain Technology in Healthcare.

Major stakeholders, key companies Blockchain Technology in Healthcare, investment feasibility and new market entrants study is offered.

Development scope of Blockchain Technology in Healthcare in each market segment is covered in this report. The macro and micro-economic factors affecting the Blockchain Technology in Healthcare Market

Advancement is elaborated in this report. The upstream and downstream components of Blockchain Technology in Healthcare and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/blockchain-technology-in-healthcare-market-100580

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Frozen Fruits MarketMarket

Orthopedic Insoles MarketMarket Share

Roughness And Contour Measuring Machine MarketMarket Growth Rate

Phosphatidylserine MarketMarket Forecast

Global CMP Pad Regulator MarketMarket Size

Distributed Antenna System MarketMarket Growth

Electroencephalography Equipment MarketMarket Analysis

Cloud Accounting Software MarketMarket Size

Global Packaged Cactus Water MarketMarket Share

Global Automotive Human Machine Interface (HMI) MarketMarket Growth

Synthetic Spider Silk MarketMarket

Digital Twin Technology MarketMarket Share

Self Injection Device MarketMarket Growth Rate

Application Management Services MarketMarket Forecast

Global Artificial Pancreas Device Systems MarketMarket Size

Anti-Vibration Rubber for Automotive MarketMarket Growth

Audiobooks MarketMarket Analysis

Data Annotation Tools MarketMarket Size

Global Supercapacitor Materials MarketMarket Share

Global Myopia Control Lens (Plastic Lens) MarketMarket Growth

Artificial Intelligence (AI) in Fintech MarketMarket

Non-dairy Creamer (Non Dairy Creamer) MarketMarket Share

Blockchain Technology MarketMarket Growth Rate

Testing, Inspection and Certification (TIC) MarketMarket Forecast

Global Gaseous Helium MarketMarket Size

Octreotide MarketMarket Growth

Flame Retardant Textile MarketMarket Analysis

Collagen Sponge MarketMarket Size

Global Carbon Fiber Geogrid MarketMarket Share

Global Tertiary Dodecyl Mercaptan (TDM) [Tert-Dodecyl Mercaptan] MarketMarket Growth

Software Testing MarketMarket

IOT for Fisheries and Aquaculture MarketMarket Share

Design Thinking MarketMarket Growth Rate

Laser Eye Shield MarketMarket Forecast

Global Baby Vitamin Oil Market Market Size

Lithium Battery Electrode Roll Press Machine MarketMarket Growth

Digital Special Aluminum Plastic Film Market Market Analysis

IoT Solution for Smart Waste Management MarketMarket Size

Global SGT MOSFET MarketMarket Share

Global Oligonucleotide Synthesis MarketMarket Growth

[techninja]

Eye Health Matters: The Promising Future of the Ocular Surgery Market

Introduction

The global ocular surgery market has witnessed remarkable growth and innovation over the years, driven by advancements in technology, an aging population, and an increasing prevalence of ocular disorders. Ocular surgery encompasses a wide range of procedures aimed at correcting vision problems, treating eye diseases, and improving the overall quality of life for millions of individuals. This article delves into the dynamics of the ocular surgery market, exploring key drivers, trends, challenges, and future prospects.

Market Size and Growth

The ocular surgery market has experienced substantial growth in recent years, and this trend is expected to continue. Factors contributing to this growth include a growing elderly population, a rising incidence of eye-related disorders such as cataracts, glaucoma, and macular degeneration, and increased consumer awareness about the benefits of ocular surgery. Additionally, technological advancements in surgical instruments and techniques have expanded the scope of ocular surgeries, making them safer and more effective.

Laser Vision Correction Dominance

One of the most significant trends in the ocular surgery market is the dominance of laser vision correction procedures, such as LASIK (Laser-Assisted in Situ Keratomileusis). LASIK has gained immense popularity as a safe and effective method for correcting refractive errors like myopia, hyperopia, and astigmatism. The demand for LASIK and similar procedures is expected to grow further due to their quick recovery times and high patient satisfaction rates.

Cataract Surgery Revolution

Cataract surgery remains one of the most commonly performed ocular surgeries worldwide. However, recent advancements have revolutionized this field. Traditional cataract surgery involved manually removing the cloudy lens and replacing it with an artificial intraocular lens. Modern techniques, such as femtosecond laser-assisted cataract surgery, offer more precise incisions and improved outcomes, reducing the risk of complications and enhancing patient recovery.

Robotic-Assisted Surgery

Robotic-assisted surgery is making its way into the ocular surgery market, particularly for complex procedures like retinal surgery and corneal transplants. Robots equipped with advanced imaging systems provide surgeons with greater precision and control, resulting in better patient outcomes. While this technology is still in its infancy, it holds immense promise for the future of ocular surgery.

Challenges in the Ocular Surgery Market

Despite its growth, the ocular surgery market faces several challenges. One of the main concerns is the high cost of advanced surgical equipment and procedures, which can limit access to quality eye care, especially in developing regions. Additionally, the regulatory environment for medical devices and surgical techniques varies from country to country, posing challenges for market expansion and standardization.

The COVID-19 Pandemic Impact

The COVID-19 pandemic posed unique challenges to the ocular surgery market. Elective surgeries, including many ocular procedures, were postponed or canceled during the peak of the pandemic to conserve medical resources and reduce the risk of viral transmission. This led to a temporary decline in the number of surgeries performed and delayed treatment for many patients. However, as healthcare systems adapted to the pandemic, ocular surgeries resumed, and the market showed resilience.

Future Prospects

The ocular surgery market is poised for significant growth in the coming years. The aging global population, coupled with increasing awareness of eye health, will continue to drive demand for ocular surgeries. Moreover, ongoing research and development efforts are likely to lead to more advanced and minimally invasive techniques, further improving patient outcomes and reducing surgical risks.

Conclusion

The ocular surgery market is evolving rapidly, driven by technological advancements, changing demographics, and a growing emphasis on eye health. Laser vision correction procedures, innovative cataract surgery techniques, and the potential for robotic-assisted surgery are shaping the future of this dynamic field. Despite challenges such as cost barriers and regulatory complexities, the ocular surgery market is expected to expand, offering hope for millions of individuals seeking improved vision and a better quality of life.

[futuristicpaintercat]

 "Myopia Control Lenses Market Expected to Reach US$ 1.26 Billion by 2023"

Market Overview: The global Myopia Control Lenses market is estimated to be valued at US$ 1.26 Billion In 2023, with a projected compound annual growth rate (CAGR) Of 17% From 2023 To 2030, according to a report published by Coherent Market Insights. These lenses offer various advantages, including the ability to slow down the progression of myopia among individuals. The need for such products arises as myopia, or nearsightedness, continues to be a prevalent eye condition worldwide, affecting a large segment of the population.

Market Key Trends: One key trend in the Myopia Control Lenses market is the rise in technological advancements. Manufacturers are continuously investing in research and development to provide innovative solutions to address the growing demand for myopia control. For instance, Essilor International has developed the Myopilux Max lens, which combines distance center optics with Defocus Incorporated Multiple Segments (DIMS) technology, effectively managing peripheral defocus and controlling myopia progression. The integration of such advancements is expected to drive market growth in the coming years. Porter's Analysis: Threat of new entrants: The market barriers for new entrants are relatively high due to the requirement of substantial investments in research and development, as well as regulatory approvals. Established players have already gained significant market share, making it difficult for new companies to enter the market. Bargaining power of buyers: Buyers have a moderate bargaining power as there is a range of lens options available in the market. However, the key players' strong brand reputation and their ability to provide innovative products give them some advantage in negotiating with buyers. Bargaining power of suppliers: Suppliers have a moderate bargaining power as they face competition from multiple players in the market. Lens manufacturers source their raw materials from various suppliers, reducing their dependency on a single supplier. Threat of new substitutes: The threat of new substitutes is low as myopia control lenses provide specific benefits that cannot be easily replicated by other products. The effectiveness of these lenses in managing myopia progression makes them a preferred choice among individuals and eye care professionals. Competitive rivalry: The Myopia Control Lenses market is highly competitive, with key players such as Essilor International, Johnson & Johnson Vision, CooperVision, Hoya Corporation, and Zeiss Group dominating the market. These players often engage in product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive edge. Key Takeaways: Market size related content: The Global Myopia Control Lenses Market Demand Is Expected To Witness High Growth, exhibiting a CAGR Of 17% over the forecast period. This growth can be attributed to the increasing prevalence of myopia worldwide. Factors such as lifestyle changes, prolonged near work activities, and reduced time spent outdoors contribute to the rising demand for myopia control solutions. Regional analysis: Asia Pacific is expected to be the fastest-growing and dominating region in the Myopia Control Lenses market. The region's high myopia prevalence, especially among children and young adults, is driving the demand for myopia control lenses. Additionally, increasing awareness and access to healthcare facilities are further propelling market growth in the region. Key players analysis: Key players operating in the global Myopia Control Lenses market include Essilor International, Johnson & Johnson Vision, CooperVision, Hoya Corporation, Zeiss Group, Bausch + Lomb, Menicon Co., Ltd., SEED Co., Ltd., Alcon (Novartis), Visioneering Technologies Inc., Paragon Vision Sciences, Euclid Systems Corporation, Art Optical Contact Lens Inc., SynergEyes Inc., and Nevakar Inc. These companies dominate the market due to their strong product portfolios, extensive distribution networks, and continuous investments in research and development. In conclusion, the Myopia Control Lenses market is expected to experience significant growth in the coming years, driven by advancements in technology and the increasing prevalence of myopia. Key players' strategic initiatives and collaborations will play a crucial role in shaping the market landscape.

[market-insider]

Myopia and Presbyopia Treatment: Emerging Technologies and Innovations

Both myopia and presbyopia are common vision conditions that can impact daily activities. Myopia, commonly known as nearsightedness, is a refractive error of the eye that causes distant objects to appear blurry, while close objects can be seen clearly. It occurs when the eyeball is slightly longer than normal or when the cornea (the clear front surface of the eye) has excessive curvature. As a result, light entering the eye focuses in front of the retina instead of directly on it, leading to blurred distance vision. People with myopia may have difficulty seeing road signs, distant objects, or the blackboard in a classroom. Myopia can develop during childhood and typically stabilizes in early adulthood, but in some cases, it may progress. Presbyopia is an age-related condition characterized by the gradual loss of the eye's ability to focus on close objects. It occurs due to a natural aging process that affects the lens inside the eye. The lens gradually becomes less flexible, making it challenging to focus on nearby objects, such as reading material or a smartphone. Presbyopia typically becomes noticeable around the age of 40 and continues to progress until around the age of 60. People with presbyopia may experience eye strain, difficulty reading small print, or the need to hold reading material at arm's length to see it clearly. It is a normal age-related change in vision and affects virtually everyone to some extent.

Gain deeper insights on the market and receive your free copy with TOC now @: Myopia And Presbyopia Treatment Market Report

Recent developments in Myopia Treatment:

Orthokeratology (Ortho-K) involves the use of specially designed gas-permeable contact lenses that are worn overnight to reshape the cornea temporarily. This technique aims to reduce or control myopia progression, particularly in children. Ongoing research has been exploring the effectiveness and safety of Ortho-K for myopia management. Studies have shown that low-dose atropine eye drops can slow down the progression of myopia in children. This treatment involves using a diluted concentration of atropine, a medication that temporarily dilates the pupils and relaxes the eye's focusing mechanism. Research has been focused on determining the optimal dosage and long-term effects of this treatment.

Recent developments in Presbyopia Treatment:

Intraocular lenses are artificial lenses implanted during cataract surgery to replace the eye's natural lens. Advancements in the design of accommodative IOLs aim to provide improved near vision by allowing the lens to change its shape or position, mimicking the natural focusing ability of the eye. Ongoing research continues to refine the technology and assess its long-term outcomes. Corneal inlays are small devices implanted into the cornea to enhance near vision in individuals with presbyopia. These inlays alter the eye's focusing power to improve near vision while maintaining good distance vision. Different types of corneal inlays are being developed, and clinical studies are underway to evaluate their safety and effectiveness. Laser blended vision is a technique that uses LASIK or PRK to adjust the dominant eye for distance vision and the non-dominant eye for near vision, creating a balance for improved overall vision. This approach aims to provide a range of vision for both near and distance tasks, reducing the need for reading glasses.

[healthcaremarketfmi]

Myopia and Presbyopia Treatment Market Size, Share, Future Road-map, Technological Innovations & Growth Forecast To 2032

The global myopia and presbyopia treatment market is set to witness an impressive growth rate of 8.5% over the forecasted years of 2022 to 2032. The myopia and presbyopia treatment market size is anticipated to reach a valuation of around US$ 40.5 Billion by the end of year 2032 from the current valuation of US$ 17.9 Billion in 2022.

According to the ‘World Report on Vision 2019’ issued by the World Health Organization, the yearly global costs of productivity losses linked with vision impairment from untreated myopia alone were projected to be US$ 244 Billion. In comparison to the preceding five years, the prevalence of myopia has climbed from 1.4% to 3% as revealed by myopia and presbyopia treatment market analysis report in 2020. As an inference, given the increase in myopia instances, the overall myopia and presbyopia treatment market is anticipated to rise rapidly over the next years.

Increasing government funding for conditions that cause visual impairment could help myopia and presbyopia treatment market size develop more broadly during the projected period. Additionally, the ability to prevent significant health problems including glaucoma, cataracts, and retinal damage if the condition is identified and treated early enough is also expected to fuel the expansion of the worldwide myopia and presbyopia treatment market during the projection period.

The myopia and presbyopia market growth is favored due to the rapid improvement in the treatment procedures and the expansion of eye clinics. Increase in the prevalence of visual impairments and brought on by these disorders and are observed to be boosting the global myopia and presbyopia treatment market share.

Higher use of contact lenses among the younger generation of present age, as well as surgical alternatives across the countries have boosted the myopia and presbyopia treatment business significantly.   Furthermore, the myopia and presbyopia treatment market opportunities is expanding as a consequence of technological introductions, an increase in optometrists, and rising consumer knowledge of available treatment alternatives.

For More Information : https://www.futuremarketinsights.com/reports/myopia-and-presbyopia-treatment-market

Key Takeaways from Myopia and Presbyopia Treatment Market Study

The overall growth of the global myopia and presbyopia treatment market is estimated to be around US$ 20.6 Billion over the forecasted years of 2022 to 2032 by following the average CAGR of 8.5%.

The net worth of the myopia and presbyopia treatment market size is predicted to reach around a valuation of US$ 40.5 Billion by the end of the year 2032.

In the myopia treatment market segment, the single prescription treatment is the dominating category of the overall market with revenue share of more than 30% generated globally.

In the presbyopia treatment category, the prescription lenses segment holds the largest share of more than 25% of the revenue generated globally.

Among the broad geographical regions, US myopia and presbyopia treatment market leads the target market with a strong foundation and infrastructure for the technological innovations pertaining to ocular treatment.

Competitive Landscape

Some of the well-known myopia and presbyopia treatment market players are Ziemer Ophthalmic Systems AG, NIDEK CO., LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated, Haag-Streit UK, and Topcon Corporation among others.

Recent Developments in the Global Myopia and Presbyopia Treatment Market:

CooperVision began the Take Control: Myopia & You education campaign in October 2021 with the goal of raising attention and inspiring parents to seek eye checkups for their kids mostly in United States.

The Max orthokeratology lens from Euclid Systems Corp. was introduced in June 2021 that is intended to momentarily decrease myopia incidences.

[akashpawar0412]

**Myopia Control Lens Market Outlook Report Forecast 2022-2028**

The global Myopia Control Lens (Plastic Lens) market size is estimated to be worth US$ 604.94 million in 2021 and is forecast to a readjusted size of US$ 2,342.17 million by 2028 with a CAGR of 20.26% during the review period.

Myopia, also known as nearsightedness, is a condition in which distant objects appear blurry while close objects are clear. Myopia occurs when the eyeball is too long or when the cornea, the clear front surface of the eye, has too much curvature. Light rays entering the eye are focused in front of the retina instead of on the retina. This causes distant objects to appear blurry.

Report Sample includes: - Table of Contents - List of Tables & Figures - Charts - Research Methodology

Get FREE Sample of this Report at https://www.intelmarketresearch.com/download-free-sample/11/myopia-control-lens-market

Myopia typically develops in childhood and continues to progress through adolescence. Nearly one-third of Americans are myopic, and myopia is on the rise globally.

This report focuses on Myopia Control Lens (Plastic Lens) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Myopia Control Lens (Plastic Lens) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, South Korea, Taiwan, etc.

The research report includes specific segments by region (country), by company, by Type and by End User. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment Analysis:

The research report includes specific segments by region (country), by manufacturers, by Type and by End User. Each type provides information about the production during the forecast period of 2017 to 2028. By End User segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

The global major manufacturers of Myopia Control Lens (Plastic Lens) include ZEISS, HOYA Corporation, EssilorLuxottica, Ovctek, Alpha Corporation, Paragon (CooperVision), EUCLID, Brighten Optix, and Lucid Korea, etc. In terms of revenue, the global 3 largest players have a 49.10% market share of Myopia Control Lens (Plastic Lens) in 2021.

ZEISS

HOYA Corporation

EssilorLuxottica

Ovctek

Alpha Corporation

Paragon (CooperVision)

EUCLID

Brighten Optix

Lucid Korea

Procornea (CooperVision)

WeiXing Optical

Contex

Jiangsu Green Stone Optical (SETO)

Conant

ZEISS

Segment by Type

Myopia Control Spectacle Lenses accounting for 59.60% of the Myopia Control Lens (Plastic Lens) global market in 2021, is projected to value US$ 1,443.36 million by 2028, growing at a revised 20.71% CAGR in the post-COVID-19 period. While Children (6-12 Years Old) segment is altered to a 20.37% CAGR throughout this forecast period and will hold a share about 89.21% in 2028.

Myopia Control Spectacle Lenses

Orthokeratology Lens

Segment by End User

Children (6-12 Years Old)

Teenagers (12-18 Years Old)

Consumption by Region

North America

U.S.

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

China Taiwan

Southeast Asia

India

Australia

Rest of APAC

Europe

Germany

France

U.K.

Italy

Russia

Spain

Rest of Europe

Latin America

Brazil

Argentina

Colombia

Rest of Latin America

Market Drivers:

Myopia, or nearsightedness, is a growing problem worldwide. The condition affects approximately 1.4 billion people globally, and the number is expected to rise to nearly 5 billion by 2050. Myopia occurs when the eye grows too long, preventing light from focusing directly on the retina and resulting in blurred vision.

There are several factors driving the myopia control lens market. One is the increasing prevalence of myopia, especially among children and young adults. This is due in part to increased screen time and other near work activities. Another driver is the availability of new myopia control lenses that can slow down the progression of myopia and even improve vision in some cases. And finally, insurance coverage for myopia control lenses is increasing, making them more accessible to patients.

With the rising prevalence of myopia and the availability of new, effective treatments, the myopia control lens market is expected to grow significantly in the coming years.

Market Challenges:

The myopia control lens market faces several challenges that may hamper market growth in the forecast period. These include high costs associated with myopia control lenses, lack of awareness among consumers, and competition from other vision correction options. Additionally, myopia is often diagnosed in young children, who may be unwilling or unable to wear corrective lenses. This presents a significant challenge for market growth, as early intervention is key to effective myopia control.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the markets competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Cy Bar Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis

Market dynamics scenario, along with growth opportunities of the market in the years to come

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects

Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

Market value (USD Million) and volume (Units Million) data for each segment and sub-segment

Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

1-year analyst support, along with the data support in excel format.

Get the Complete Report & TOC at https://www.intelmarketresearch.com/life-sciences/11/myopia-control-lens-market

CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 Email: help@intelmarketresearch.com Follow Us On linkedin :- https://www.linkedin.com/company/intel-market-research/

[amobilityequipment-blog]

Mobility Equipment And Their Common Myths

Being unable to take action due to a handicap is saddening, as well as it hurts your self-esteem. Disability of those thighs or the whole lower-limb will compromise your capacity to mobilise. There's an entire range of disabled equipment that aims to aid people with any form of disability. Basically, almost every thing or thing we all now have is assumed to help us with some thing, but the handicap equipment is always to help maintain or regain your body's work. To maintain the function closest to normal may be the masterplan behind the range of equipment. Disabled equipment covers a broad list of products of all shapes and sizes. They are not restricted to equipment which is tasked to assist you mobilise or help you in walking. They comprise all things which can aid people. As an example, a person who has a disability to see things vividly due to an eye condition such as myopia, and maybe astigmatism, wearing a contact lens is just a form of assistance. Browse the below mentioned website, if you are seeking for additional information regarding uk mobility aids.

As people could be vulnerable to situations which may leave them with various disabilities, a growing number of disabled equipment is being made to suit people's preference and conditions. Items which usually are available are mobility aids including walkers, crutches, wheelchairs and gaits. These help with mobility problems that usually are due to accidents of deformities of their legs. Other equipments include kitchen guides, bathing and shower assists, drinking and eating assists and writing aids. The goal is to help every individual just as much as you possibly can to maintain regular routine activities like they had the condition resulting in the handicap. There are always a great deal of providers of disabled equipment. You may even ask your doctor what sort of equipment is suitable for your situation.

Because these products usually are attached to a own health state, the physician you have is sure to have replies and suggestions for your own interest. Products from the market usually are modern, high quality, user friendly and are userfriendly. Since it's designed to allow you to on daily basis, you may even throw your doubts aside durability shrewd. Also, it is often feasible to watches or trial as counseling or walking aids have been demonstrated, which really helps to ascertain if a particular product is suited to your individual needs. Getting disabled or using a certain handicap should not stop somebody from leading a regular daily lifestyle. When buying a mobility device, it is always a fantastic idea to complete quality checks. Something might look terrific at a catalog, but the real device may tell a different narrative. Be certain that all pieces are working and all controls are all fully functioning. It's also sensible to take a review of the quality of the material a device is made out of. Being cautious will probably make sure that an appropriate apparatus is purchased and used.

[marketinsightshare]

Vision Disorders Market - Forecast, 2022-2027

Vision Disorders Market Size is estimated to reach $47.4 billion by 2027. Furthermore, it is poised to grow at a CAGR of 7.1% over the forecast period of 2022-2027. Vision Disorders are defined as any impairment in the normal sense of vision. Myopia, hyperopia, astigmatism, presbyopia, conjunctivitis, cataract, corneal abrasion, entropion, and glaucoma are only a few of the vision diseases that impact the vast majority of the world's population. The majority of vision impairments are caused by poor nutrition, different diseases, severe eye injury, insertion of foreign objects, and advancing age. Despite tremendous advances in preventing and curing visual impairment in many countries over the last two decades, the World Health Organization (WHO) estimates that over 285 million people worldwide are still visually impaired in 2013. According to the WHO, simple eye examinations such as aberrant blinking frequency, pupil size, and eye color can heal 80 percent of visually impaired patients. Clinical and retinal examinations such as corneal topography, keratometry, pachymetry, fluorescein angiography, Indocyanine Green study (ICG) dye test, and other related studies can confirm the diseases. Ignorance and neglect, on the other hand, might result in serious eye issues or irreversible vision loss. In 2004, the Centers for Disease Control and Prevention (CDC) published research estimating that around 14 million Americans over the age of twelve were affected by various vision impairments, eyeglasses, and contact lenses are generally used in eyesight. Silicone hydrogel contact lenses are a type of advanced soft contact lens that allows more oxygen to pass through to the cornea than traditional soft ("hydrogel") contacts.

Vision disorders Market Report Coverage

The report: “Vision Disorders Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Vision Disorders Market.

By Disease Type- Dry Eye, Eye Allergies, Glaucoma, Cataract, Pterygium, Retinopathy, Eye Infection, Retinal Disorders, Uveitis, and Others.

By Product Type- OTC Drugs, and Prescription Drugs.

By Drug Class- Anti-allergy, Anti-inflammatory, Anti-VEGF (Vascular Endothelial Growth Factor), Anti-glaucoma, Antibacterial, and Others.

By Treatment Type- Drugs, Devices, Others.

By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

Geographically, North America held a dominant market share in the year 2021 on account of increasing pharmaceutical industries. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to the increasing manufacturing of ophthalmic products in the pharmaceutical industries. The proliferation of ophthalmic products is predicted to augment the market growth during the forecast period of 2022-2027.

The growing number of ophthalmic pharmaceutical companies entering into strategic initiatives coupled with rising awareness regarding gene therapies are estimated to drive the market growth of the Vision Disorders Market. The growing number of patent expiry of blockbuster drugs poses threat to the Vision Disorders Market growth.

A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Vision Disorders Market Report.

Vision Disorders Market: Market Share (%) by region, 2021

For more details on this report - Request for Sample

Vision Disorders Market Segment Analysis – By Disease Type

Vision Disorders Market based on disease type can be further segmented into Dry Eye, Eye Allergies, Glaucoma, Cataract, Pterygium, Retinopathy, Eye Infection, Retinal Disorders, Uveitis, and Others. The Cataract segment held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 8.1% over the forecast period of 2022-2027. The increasing prevalence of cataracts is consequently increasing the Eye disorders Market. According to WHO, in 2019, In underdeveloped countries, the occurrence of cataracts similarly rises with age, though it begins sooner in life and is more common. Visually significant cataracts, for example, occurred 14 years earlier in an Indian study than in a comparable study in the United States. The age-adjusted prevalence of cataracts in India was three times that of the United States, with 82 percent of Indians aged 75 to 83 years old having visually significant cataracts or aphakia, compared to 46 percent of those aged 75 to 85 years in the United States (senile lens changes associated with a visual acuity of 6/9 or worse, or a history of cataract extraction). Moreover, at the same point, glaucoma prevalence is also increasing. Hence, cataracts and glaucoma are expected to propel the market of eye disorders in the forecast period 2022-2027.

Vision Disorders Market Segment Analysis – By Drug class

Vision Disorders Market based on Drug class can be further segmented into Anti-allergy, Anti-inflammatory, Anti-VEGF (Vascular Endothelial Growth Factor), Anti-glaucoma, Antibacterial, and Others. The Risk Management & Safety Solution segment held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 8.9% over the forecast period of 2022-2027. Owing to the increasing prevalence of eye diseases especially age-related macular degeneration, and diabetic retinopathy. Anti-VEGF drugs prevent aberrant blood vessels from leaking, developing, and bleeding beneath the retina. The protein vascular endothelial growth factor (VEGF) encourages the formation of new blood vessels. It also renders blood vessels more prone to leakage. Anti-VEGF drugs block the formation of new blood vessels. Anti-VEGF medication has been approved for age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and myopic choroidal neovascularization in the treatment of vascular and exudative diseases of the retina. Lucentis (ranibizumab) and Avastin are the two most extensively utilized medications at the moment (bevacizumab). Both medications are monoclonal antibodies that attach to each of the three types of VEGF, hence expanding the segment growth.

Vision Disorders Market Segmentation Analysis- By Geography

The Vision Disorders Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 31% in the year 2021 as compared to the other counterparts on account of increasing pharmaceutical industries. Furthermore, the presence of prominent competitors in this area, such as Pfizer, Inc., and Alcon, is projected to boost the market growth. For example, Alcon got FDA approval for Pataday Once Daily Relief and Pataday Twice Daily Relief for OTC sale in the United States in February 2020. The Pataday brand is used to treat itching and allergies in the eyes.

However, Asia-Pacific is estimated to be the fastest-growing over the forecast period of 2022-2027 on account of rising healthcare expenditure, and demand for better healthcare facilities. Local businesses are launching strategic endeavors to create and market innovative patient treatment solutions. As a result, market growth is likely to accelerate. Bridge Biotherapeutics, Inc., for example, acquired an early-stage drug candidate for the treatment of a back-eye disorder from Konkuk University (KU) in February 2020. The therapeutic candidate is an inhibitor of a yet-to-be-identified target protein.

Vision Disorders Market Drivers

Pharmaceutical businesses in the ophthalmic field are embarking on strategic efforts that are propelling the market forward

Ophthalmic pharmaceutical firms are pursuing strategic efforts such as collaborations, acquisitions, and partnerships to add new clinical-stage prospects to their product pipelines, which is projected to enhance the market. Rising ophthalmic pharmaceutical business owing to increasing prevalence of eye disorders. According to the World Health Organization, over 2.2 billion individuals will have a vision impairment or blindness in 2021, with at least 1 billion of those having a vision impairment that can be avoided. Those with limited or severe vision impairment due to unresolved refractive error (123.7 million), cataract (65.2 million), glaucoma (6.9 million), corneal opacities (4.2 million), diabetic retinopathy (3 million), and trachoma (2 million), as well as those with imminent vision impairment due to unspecified presbyopia (1.2 billion) (826 million). The growing senior population is exacerbating the prevalence of ocular illnesses, with uncorrected refractive errors and cataracts being the leading causes of vision impairment. The majority of people with vision problems are above the age of 50, enhancing the Vision Disorders Industry.

Rising prevalence of lifestyle changing diseases, especially diabetes is driving the Market for Vision Disorders

According to CDC, in 2021, Diabetic retinopathy (DR) is a common diabetic condition. It is the primary cause of blindness in adults in the United States. Progressive damage of the blood vessels of the retina, the light-sensitive tissue at the back of the eye that is required for good vision, characterizes it. Mild nonproliferative retinopathy (microaneurysms), moderate nonproliferative retinopathy (blockage in some retinal vessels), severe nonproliferative retinopathy (more vessels are blocked, depriving the retina of blood supply, resulting in the formation of new blood vessels), and proliferative retinopathy (growth of new blood vessels) are the four stages of DR (most advanced stage). Both eyes are generally affected by diabetic retinopathy.

Disease management, which includes adequate control of blood sugar, blood pressure, and lipid abnormalities, reduce the risk of DR. Early detection and treatment of DR lessen the risk of vision loss; nevertheless, up to 50% of patients do not have their eyes tested or are detected too late for effective therapy. It is the primary cause of blindness among working-age adults in the United States, ages 20 to 74. Retinopathy and vision-threatening retinopathy impact an estimated 4.1 million and 899,000 Americans, respectively, thereby driving the market growth.

Vision Disorders Market Challenges

The increasing number of blockbuster medicine patents expiring is projected to stifle Market growth of Vision Disorders

Pharmaceutical businesses will lose exclusivity when their patents expire, but medication producers will be granted new chances and difficulties as the generic competition enters the market. The introduction of generic glaucoma eye drops to the market has lowered patient expenses and increased adherence in some patients thereby decreasing the prevalence of glaucoma disorder Market. For instance, Prostaglandin analogs are anticipated to cost patients more than $100 per month on average across the country. When the first generic prostaglandin analog was introduced in 2011, it was projected that patients switching to the generic version would save more than $1,300 per year. 5 A 30-day prescription for generic latanoprost costs between $19 and $30, according to recent data on www.GoodRx.com, where we practice in mid-Missouri, whereas the same prescription for Xalatan (latanoprost ophthalmic solution; Pfizer) costs between $139 and $154. Hence, the increasing number of blockbuster medicine patents expiring is projected to stifle Market growth of Vision Disorders.

Vision Disorders Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Vision Disorders Market. The top 10- Vision Disorders Market companies are-

Croda International Plc

AbbVie Inc

Aerie Pharmaceuticals, Inc.

Novartis AG

AkzoNobel N.V.

F. Hoffmann-La Roche Ltd.

Evonik Industries

PolyOne Corporation

DuPont

Addcomp Holland

Recent developments

In November 2021, Aerie Pharmaceuticals received marketing authorization approval from the European Commission for its Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle.

In October 2021, Abbvie Inc. launched a new drug named VUITYTM (pilocarpine HCl ophthalmic solution). Presbyopia, often known as age-related hazy near vision, is treated with VUITYTM (pilocarpine HCl ophthalmic solution) 1.25 percent in adults. VUITY is the first and only FDA-approved eye drop to treat this prevalent and degenerative eye disease, which affects 128 million Americans, or over half of the adult population in the United States.

In September 2021, Novartis acquired Arctos Medical, bolstering its ophthalmology portfolio with a pre-clinical optogenetics-based AAV gene therapy program and Arctos' proprietary technology. Novartis' dedication to finding solutions for individuals with vision loss, as well as the potential of optogenetics as a foundation for successful therapeutics, is shown in this acquisition.

[crossingoptical]

CONCERNED ABOUT YOUR CHILD’S VISION? See if your child can be fit for the latest myopia control Lens available. MiYOSMART® by Hoya is generally recommended for children aged 6-18 or whenever the first signs of myopia appear. MiYOSMART Lenses are:   Easy - just by wearing it daily  Effective - slows down power progression by an average of 60%   Non-invasive - safe and easy adaptation   Award-winning - recognized internationally   has Clinically proven - backed by intensive research and evidence-based   MiyoSmart is an innovative spectacle lens developed to treat myopia jointly developed by Hoya and Hong Kong Polytechnic University. With research conducted for over 6 years and based on two-year clinical trial results, MiyoSmart with its award-winning D.I.M.S technology is proven to reduce myopia progression by an average of 60%. We at Crossing Optical are proud to be a certified MiyoSmart specialist and one of the selected authorized dealers to market this new amazing product. Please contact us for more information about how MiYOSMART could help to control your child’s myopia. Parents who are concerned about their children’s vision are welcome to bring their children to see us for a detailed vision assessment + evaluation. #MyopiaControl #hoyalenses #hoyacanada #miyosmart #myopiaprogression #slowdownmyopia #CrossingOptical (at Crossing Optical Inc.) https://www.instagram.com/p/CibPLJoPkDZ/?igshid=NGJjMDIxMWI=

[lasik-surgery-in-delhi]

LASIK Eye Surgery FAQ’s - Lasikdelhi

Q. What is LASIK?

A. LASIK, the short form of laser in-situ keratomileusis, is a surgical procedure done to correct the vision. The correction of eyesight is done in patients suffering from myopia, hyperopia, and astigmatism. It is one of the most performed surgery all-overs the world with a high success rate. This procedure provides prolonged freedom from glasses and contact lens to the patient. This surgery comes under the refractive correction procedure as it helps in correcting the refractive errors in vision. The person may experience immediate enhancement in the vision. Barring few complications which can be minimized through proper preoperative evaluation and appropriate surgical technique and expertise the surgery is considered as one of the safest.

Q. How is LASIK surgery performed?

A. LASIK is laser vision correction procedure utilizing a laser called EXCIMER laser. These are high energy beam which transfers the energy to corneal tissues. The surgery is done through computer-controlled laser for high accuracy and precision and the energy so transferred to the corneal tissue causes corneal reshaping by vaporizing a small quantity of tissues.The surgery takes place in two steps. In the FIRST step, a very thin and hinged corneal flap is formed with the help of a laser ( femtolasik or blade free lasik ) or automated microkeratome ( blade lasik ). In the SECOND step, the flap is pulled to expose the underlying corneal tissue and the excimer laser is used to reshape the cornea by removing a small amount of corneal tissue. After reshaping the cornea, the flap is then repositioned on the cornea.

Q. What are the expected results from LASIK surgery?

A. LASIK surgery is performed to avoid the dependency on glasses and contact lenses. Allmost all patients are happy with the outcome. However, the results vary from individual to individual, Various factors affect the quality of results obtained through LASIK surgery. Important are surgeons expertise, the technology used and appropriate patient and technique selection. Preoperative evaluation plays a pivotal role in determing the satisfactory and successful visual outcome. To achieve the best results, a thorough ophthalmological examination is a prerequisite to establishing candidature to undergo LASIK surgery. The experience of the surgeon and the technology used to perform LASIK surgery are other important factors that may make a difference on LASIK outcome.

Q. What are the benefits of LASIK Surgery?

A. The laser is a highly effective and safe surgery for correcting refractive errors. LASER surgery is commonly used to correct myopia, hyperopia, and astigmatism because of various advantages it offers to the patients. Various advantages offered by LASIK surgery include:Outcome: LASIK surgery meets the expectation of almost 96% of the patient in one go and the number further increases through revision surgery. It was introduced in the market almost 25 years ago and is still the mainstay for correcting refractive errors.

Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia

.Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia.

Immediate result: Most patients experienced enhanced vision immediately after surgery while others have improved vision within 24 hours.

No stitches: The surgery does not involve any stitches or bandages.

Q. What are the risks with LASIK surgery?

A. LASIK surgery involves certain risk but these can be minimized by the implementation of high-technology instruments, undergoing surgery from an experienced surgeon and adequate post-operative care. Following are some of the complications associated with LASIK surgery:

 Risk of infection: Antibiotics are prescribed before and after the surgery to minimize or avoid the infection. If the patient fails to adhere to the prescription, the infection may develop in the treated eye.Glare or halos: Glare and halos, especially in the people with large pupil, may also occur after LASIK surgery. It is minimized using an aspheric wavefront optimized profile on the advanced MEL 80 excimer laser systems from CARL ZEISS (GERMANY).

Dry Eyes: Dryness may be induced after LASIK surgery through the period differs from patient to patient. Lubricating eye drops are prescribed post-surgery.

Fluctuation in the vision: may happen in initial postoperative period but settles within a weeks time.Other rare complications: Other rare but serious complications include scarring, the problem in equipment during surgery, and flap-related complications.

Q. Am I the right candidate for LASIK surgery?

A. For determining the eligibility of the candidate for LASIK surgery, a comprehensive evaluation of the eye is required. Following are the right candidates for LASIK surgery:Should be over 18 years of age Should be in a healthy state to bear the stress of surgery. Should not suffer from any underlying unmanaged medical condition such as unmanaged hypertension or uncontrolled diabetes. Should not be pregnant or breastfeeding.

Q. How should I choose the best surgeon for LASIK surgery?

A. Choosing the best ophthalmological surgeon for LASIK surgery requires a lot of research and gathering information about various surgeons. Following elements help you in deciding the best surgeon for LASIK surgery: Experience: The experience of the surgeon is one of the important considerations for safe surgery. Risks of complications increase manifold when an inexperienced surgeon does the surgery. You should always check the experience of the surgeon and the number of LASIK surgeries he had done. At BAJAJ EYE CARE CENTRE we have experienced surgeons who have done thousands of successful procedures. Infrastructure: Clinics or hospitals which invest much in infrastructure are believed to have the high-end and latest technology. Gather information about the technology used during the surgery. BAJAJ EYE CARE CENTRE uses the most advanced technology from the world leaders in laser vision correction procedures – CARL ZEISS VISUMAX FEMTOSECOND LASER machine for blade free lasik and the MEL 80 EXCIMER LASER machine for bladefree and blade lasik. BAJAJ EYE CARE CENTRE is also the first centre to install ZEISS VISUMAX – SMILE machine for flapless and totally blade free lasik in whole of NORTH DELHI. Success rate: High success rate indicates the expertise of the surgeon in performing LASIK surgery.

Q. Is it safe to undergo LASIK surgery simultaneously on both the eyes?

A. YES. Most of the laser vision correction procedures are done simultaneously on both the eyes. it saves time and restricts the number of visits to the eye centre.

Q. Do I feel pain during LASIK surgery?

A. As the surgery is performed under the effect of anesthesia, the patient does not feel any pain during the surgery. However, after the effect of anesthesia gets reduced, some patients may feel mild discomfort and irritation. However, the discomfort subsides within hours after the procedure.

Q. Will reading glasses be required after LASIK surgery?A. The need for reading glasses after LASIK surgery depends on your age. No reading glasses are required in less than 40 years of age group.

Tags - #Lasik Eye Surgery FAQ's  #Lasik Surgery Specialist in delhi,   

For more information link - https://www.lasikdelhi.com/

[lasikdelhii]

LASIK Eye Surgery In Delhi FAQ’s - Lasikdelhi

Q. What is LASIK?

A. LASIK, the short form of laser in-situ keratomileusis, is a surgical procedure done to correct the vision. The correction of eyesight is done in patients suffering from myopia, hyperopia, and astigmatism. It is one of the most performed surgery all-overs the world with a high success rate. This procedure provides prolonged freedom from glasses and contact lens to the patient. This surgery comes under the refractive correction procedure as it helps in correcting the refractive errors in vision. The person may experience immediate enhancement in the vision. Barring few complications which can be minimized through proper preoperative evaluation and appropriate surgical technique and expertise the surgery is considered as one of the safest.

Q. How is LASIK surgery performed?

A. LASIK is laser vision correction procedure utilizing a laser called EXCIMER laser. These are high energy beam which transfers the energy to corneal tissues. The surgery is done through computer-controlled laser for high accuracy and precision and the energy so transferred to the corneal tissue causes corneal reshaping by vaporizing a small quantity of tissues.

The surgery takes place in two steps. In the FIRST step, a very thin and hinged corneal flap is formed with the help of a laser ( femtolasik or blade free lasik ) or automated microkeratome ( blade lasik ). In the SECOND step, the flap is pulled to expose the underlying corneal tissue and the excimer laser is used to reshape the cornea by removing a small amount of corneal tissue. After reshaping the cornea, the flap is then repositioned on the cornea.

Q. What are the expected results from LASIK surgery?

A.LASIK surgery is performed to avoid the dependency on glasses and contact lenses. Allmost all patients are happy with the outcome. However, the results vary from individual to individual, Various factors affect the quality of results obtained through LASIK surgery. Important are surgeons expertise, the technology used and appropriate patient and technique selection. Preoperative evaluation plays a pivotal role in determing the satisfactory and successful visual outcome. To achieve the best results, a thorough ophthalmological examination is a prerequisite to establishing candidature to undergo LASIK surgery. The experience of the surgeon and the technology used to perform LASIK surgery are other important factors that may make a difference on LASIK outcome.

Q. What are the benefits of LASIK Surgery?

A.The laser is a highly effective and safe surgery for correcting refractive errors. LASER surgery is commonly used to correct myopia, hyperopia, and astigmatism because of various advantages it offers to the patients.

Various advantages offered by LASIK surgery include:

Outcome: LASIK surgery meets the expectation of almost 96% of the patient in one go and the number further increases through revision surgery. It was introduced in the market almost 25 years ago and is still the mainstay for correcting refractive errors.

Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia.

Pain-free: The LASIK surgery is virtually painless as it is done under the effect of anesthesia.

Immediate result: Most patients experienced enhanced vision immediately after surgery while others have improved vision within 24 hours.

No stitches: The surgery does not involve any stitches or bandages.

Q. What are the risks with LASIK surgery?

A. LASIK surgery involves certain risk but these can be minimized by the implementation of high-technology instruments, undergoing surgery from an experienced surgeon and adequate post-operative care. Following are some of the complications associated with LASIK surgery:

Risk of infection: Antibiotics are prescribed before and after the surgery to minimize or avoid the infection. If the patient fails to adhere to the prescription, the infection may develop in the treated eye.

Glare or halos: Glare and halos, especially in the people with large pupil, may also occur after LASIK surgery. It is minimized using an aspheric wavefront optimized profile on the advanced MEL 80 excimer laser systems from CARL ZEISS (GERMANY)

Dry Eyes: Dryness may be induced after LASIK surgery through the period differs from patient to patient. Lubricating eye drops are prescribed post-surgery.

Fluctuation in the vision: may happen in initial postoperative period but settles within a weeks time.

Other rare complications: Other rare but serious complications include scarring, the problem in equipment during surgery, and flap-related complications.

Q. Am I the right candidate for LASIK surgery?

A.For determining the eligibility of the candidate for LASIK surgery, a comprehensive evaluation of the eye is required. Following are the right candidates for LASIK surgery:

Should be over 18 years of age

Should be in a healthy state to bear the stress of surgery.

Should not suffer from any underlying unmanaged medical condition such as unmanaged hypertension or uncontrolled diabetes.

Should not be pregnant or breastfeeding.

Q. How should I choose the best surgeon for LASIK surgery?

A.Choosing the best ophthalmological surgeon for LASIK surgery requires a lot of research and gathering information about various surgeons. Following elements help you in deciding the best surgeon for LASIK surgery:

Experience: The experience of the surgeon is one of the important considerations for safe surgery. Risks of complications increase manifold when an inexperienced surgeon does the surgery. You should always check the experience of the surgeon and the number of LASIK surgeries he had done. At BAJAJ EYE CARE CENTRE we have experienced surgeons who have done thousands of successful procedures.

Infrastructure: Clinics or hospitals which invest much in infrastructure are believed to have the high-end and latest technology. Gather information about the technology used during the surgery. BAJAJ EYE CARE CENTRE uses the most advanced technology from the world leaders in laser vision correction procedures – CARL ZEISS VISUMAX FEMTOSECOND LASER machine for blade free lasik and the MEL 80 EXCIMER LASER machine for bladefree and blade lasik. BAJAJ EYE CARE CENTRE is also the first centre to install ZEISS VISUMAX – SMILE machine for flapless and totally blade free lasik in whole of NORTH DELHI.

Success rate: High success rate indicates the expertise of the surgeon in performing LASIK surgery.

Q. Is it safe to undergo LASIK surgery simultaneously on both the eyes?A.

YES. Most of the laser vision correction procedures are done simultaneously on both the eyes. it saves time and restricts the number of visits to the eye centre.

Q. Do I feel pain during LASIK surgery?

A. As the surgery is performed under the effect of anesthesia, the patient does not feel any pain during the surgery. However, after the effect of anesthesia gets reduced, some patients may feel mild discomfort and irritation. However, the discomfort subsides within hours after the procedure.

Q. Will reading glasses be required after LASIK surgery?

A.The need for reading glasses after LASIK surgery depends on your age. No reading glasses are required in less than 40 years of age group.

Tag = Laser Eye Centre In Delhi, LASIK Eye Surgeon In Delhi, Lasik Surgery Specialist in Delhi

For More Information https://www.lasikdelhi.com

[healthcaremarketfmi]

Myopia and Presbyopia Treatment Market is anticipated to be valued at about US$ 40.5 Billion by 2032 end

[333 Pages Report]The global myopia and presbyopia treatment market is set to witness an impressive growth rate of 8.5% over the forecasted years of 2022 to 2032. The myopia and presbyopia treatment market size is anticipated to reach a valuation of around US$ 40.5 Billion by the end of year 2032 from the current valuation of US$ 17.9 Billion in 2022.

According to the ‘World Report on Vision 2019’ issued by the World Health Organization, the yearly global costs of productivity losses linked with vision impairment from untreated myopia alone were projected to be US$ 244 Billion. In comparison to the preceding five years, the prevalence of myopia has climbed from 1.4% to 3% as revealed by myopia and presbyopia treatment market analysis report in 2020. As an inference, given the increase in myopia instances, the overall myopia and presbyopia treatment market is anticipated to rise rapidly over the next years.

Increasing government funding for conditions that cause visual impairment could help myopia and presbyopia treatment market size develop more broadly during the projected period. Additionally, the ability to prevent significant health problems including glaucoma, cataracts, and retinal damage if the condition is identified and treated early enough is also expected to fuel the expansion of the worldwide myopia and presbyopia treatment market during the projection period.

The myopia and presbyopia market growth is favored due to the rapid improvement in the treatment procedures and the expansion of eye clinics. Increase in the prevalence of visual impairments and brought on by these disorders and are observed to be boosting the global myopia and presbyopia treatment market share.

Higher use of contact lenses among the younger generation of present age, as well as surgical alternatives across the countries have boosted the myopia and presbyopia treatment business significantly.   Furthermore, the myopia and presbyopia treatment market opportunities is expanding as a consequence of technological introductions, an increase in optometrists, and rising consumer knowledge of available treatment alternatives.

Key Takeaways from Myopia and Presbyopia Treatment Market Study

The overall growth of the global myopia and presbyopia treatment market is estimated to be around US$ 20.6 Billion over the forecasted years of 2022 to 2032 by following the average CAGR of 8.5%.

The net worth of the myopia and presbyopia treatment market size is predicted to reach around a valuation of US$ 40.5 Billion by the end of the year 2032.

In the myopia treatment market segment, the single prescription treatment is the dominating category of the overall market with revenue share of more than 30% generated globally.

In the presbyopia treatment category, the prescription lenses segment holds the largest share of more than 25% of the revenue generated globally.

Among the broad geographical regions, US myopia and presbyopia treatment market leads the target market with a strong foundation and infrastructure for the technological innovations pertaining to ocular treatment.

For More information: https://www.futuremarketinsights.com/reports/myopia-and-presbyopia-treatment-market

Competitive Landscape

Some of the well-known myopia and presbyopia treatment market players are Ziemer Ophthalmic Systems AG, NIDEK CO., LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated, Haag-Streit UK, and Topcon Corporation among others.

Recent Developments in the Global Myopia and Presbyopia Treatment Market:

CooperVision began the Take Control: Myopia & You education campaign in October 2021 with the goal of raising attention and inspiring parents to seek eye checkups for their kids mostly in United States.

The Max orthokeratology lens from Euclid Systems Corp. was introduced in June 2021 that is intended to momentarily decrease myopia incidences.

Myopia and Presbyopia Treatment Market by Segmentation

By Myopia Treatment Type:

Corrective

Prescription Lenses

Single

Bifocal

Trifocal

Others

Contact Lenses

Surgical

Drugs

By Presbyopia Treatment Type:

Prescription Lenses

Reading Glasses

Bifocals

Trifocals

Progressive Multifocal

Office Progressives

Contact Lenses

Bifocal

Multifocal

Monovision

Modified Monovision

Intraocular Lenses

Refractive Surgery